M. T. Houdek, P. S. Rose, F. H. Sim, M. Hevesi, Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA P. C. Ferguson, A. M. Griffin, J. S. Wunder, University Musculoskeletal Oncology Unit, Department of Orthopedic Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
Clin Orthop Relat Res. 2019 Apr;477(4):777-784. doi: 10.1097/01.blo.0000534684.99833.10.
Bipolar endoprosthetic replacement is an option for reconstruction of the proximal femur to restore a functional extremity and salvage the limb. However, because these patients are young, there is a theoretical risk for long-term degenerative changes of the acetabulum. Currently, there is a paucity of data concerning the proportion of patients who experience degenerative acetabulum changes after reconstruction and whether these changes are associated with Musculoskeletal Tumor Society (MSTS) scores.
QUESTIONS/PURPOSES: (1) What proportion of patients develop acetabular cartilage degeneration after bipolar hemiarthroplasty for malignant tumor-related reconstructions? (2) What is the survivorship free from revision for acetabular wear, erosions, or progressive arthritis? (3) Is there an association between the presence of acetabular erosions and lower MSTS scores?
Between 2000 and 2015, 148 patients underwent endoprosthetic reconstruction of the proximal femur with a bipolar hemiarthroplasty for a malignant tumor and were potentially eligible for this retrospective study. Minimum followup was 1 year except for those who died or were revised earlier; of the 148, no patients were lost to followup before that time who were not known to have died; mean followup on the remainder was 79 months (range, 12-220 months), and the mean time to death after surgery for those who died was 28 months (range, 0-196 months). Over the course of the study, 93 (63%) patients died. The mean (± SD) patient age was 57 ± 17 years, and 55% (81 of 148) of the patients were men. We used magnification-corrected supine AP plain radiographs of the hip to evaluate degenerative acetabulum changes, and we used the 1993 MSTS score to assess function through chart review and a longitudinally maintained institutional database. We used a competing-risks survivorship estimator rather than Kaplan-Meier because of the high proportion of patients who had died during the surveillance period.
Nineteen patients (13%) developed cartilage erosion > 2 mm in the acetabulum, with two also developing protrusio after proximal femoral replacement with a bipolar endoprosthesis. Three additional patients also developed signs of protrusio. The mean acetabular wear after bipolar replacement was 1.2 mm. Patients with longer followup (p = 0.001) were at higher risk for developing acetabular wear. Six patients underwent conversion to THA to treat hip pain. At 10 years the cumulative incidence for conversion to THA for acetabular wear is 5% (95% confidence interval [CI], 0%-11%), whereas the cumulative incidence of death was 70% (95% CI, 61%-79%). There was no difference in mean MSTS scores between patients who developed > 2 mm of acetabular erosion (65% ± 25%) and those who did not (67% ± 20%; p = 0.77).
Wear was uncommon among patients with malignant hip tumors treated with bipolar endoprostheses, but the followup here was short, and some patients indeed developed wear and underwent wear-related revisions to THA. Patients expected to survive more than a few years should have periodic radiographic surveillance and should be followed for a longer period to get a better sense for whether the problem worsens with time, as we expect it may, among patients who survive for longer periods.
Level III, therapeutic study.
双极人工关节置换术是重建股骨近端以恢复功能肢体和挽救肢体的一种选择。然而,由于这些患者年轻,理论上存在髋臼长期退行性变化的风险。目前,关于恶性肿瘤相关重建后患者出现髋臼软骨退变的比例以及这些变化是否与肌肉骨骼肿瘤学会(MSTS)评分相关的数据很少。
问题/目的:(1) 双极半髋关节置换术治疗恶性肿瘤相关重建后,有多少患者出现髋臼软骨退变?(2) 髋臼磨损、侵蚀或进行性关节炎的无翻修生存率是多少?(3) 髋臼侵蚀与较低的 MSTS 评分之间是否存在关联?
2000 年至 2015 年,148 例股骨近端恶性肿瘤患者接受了双极半髋关节置换术进行重建,符合本回顾性研究的条件。除了那些更早死亡或接受翻修的患者外,随访时间不少于 1 年;在这些患者中,没有在随访时间结束前死亡但未被记录死亡的患者;其余患者的平均随访时间为 79 个月(范围,12-220 个月),而死亡患者术后的平均死亡时间为 28 个月(范围,0-196 个月)。在研究过程中,93 例(63%)患者死亡。患者的平均(± SD)年龄为 57 ± 17 岁,55%(81/148)为男性。我们使用校正放大的仰卧位骨盆前后位 X 线片评估髋臼退行性变化,并通过图表回顾和纵向维护的机构数据库使用 1993 年 MSTS 评分评估功能。由于在监测期间有大量患者死亡,我们使用竞争风险生存估计而不是 Kaplan-Meier。
19 例(13%)患者出现髋臼 > 2mm 的软骨侵蚀,其中 2 例在接受双极假体近端股骨置换后也出现了髋臼突出。另外 3 例患者也出现了髋臼突出的迹象。双极置换后髋臼的平均磨损量为 1.2mm。随访时间较长的患者(p=0.001)髋臼磨损的风险更高。6 例患者因髋关节疼痛行 THA 转换。10 年时,THA 转换治疗髋臼磨损的累积发生率为 5%(95%置信区间,0%-11%),而死亡的累积发生率为 70%(95%置信区间,61%-79%)。髋臼侵蚀 > 2mm 的患者与无髋臼侵蚀的患者之间的平均 MSTS 评分无差异(65%±25%与 67%±20%;p=0.77)。
在接受双极假体治疗的恶性髋关节肿瘤患者中,磨损并不常见,但这里的随访时间较短,确实有一些患者出现了磨损并进行了与磨损相关的 THA 翻修。预计生存时间超过数年的患者应定期进行影像学监测,并应进行更长时间的随访,以更好地了解随着时间的推移,问题是否会恶化,我们预计在生存时间较长的患者中会出现这种情况。
III 级,治疗性研究。